by Biotechnology Focus •
January 19, 2016 •
Drug Development, Science Focus •
Comments (0) •
Toronto, ON and Vancouver, BC— A novel drug therapy to reduce the severity and frequency of hypoglycemic (low blood sugar) episodes in people with diabetes is being developed by Zucara Therapeutics Inc.
Comments are closed.
© 2017 Biotechnology Focus™
Powered by Wordpress. Designed by Themnific™